132 related articles for article (PubMed ID: 22426488)
81. Natural products modulate cell apoptosis: a promising way for treating endometrial cancer.
Zhou X; Zeng Y; Zheng R; Wang Y; Li T; Song S; Zhang S; Huang J; Ren Y
Front Pharmacol; 2023; 14():1209412. PubMed ID: 37361222
[TBL] [Abstract][Full Text] [Related]
82. Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.
de Barros Machado A; Dos Reis V; Weber S; Jauckus J; Brum IS; von Eye Corleta H; Strowitzki T; Capp E; Germeyer A
Oncol Lett; 2016 Nov; 12(5):3626-3632. PubMed ID: 27900046
[TBL] [Abstract][Full Text] [Related]
83. Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer.
Wang L; Zhou W; Li H; Yang H; Shan N
Front Oncol; 2020; 10():1468. PubMed ID: 32983981
[No Abstract] [Full Text] [Related]
84. Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway.
Wang Y; Zhu Y; Zhang L; Tian W; Hua S; Zhao J; Zhang H; Xue F
Cancer Lett; 2012 Sep; 322(2):223-31. PubMed ID: 22459351
[TBL] [Abstract][Full Text] [Related]
85. The roles and clinical applications of interleukins in endometrial carcinoma.
Zang Y; Li H; Liu S; Zhao R; Zhang K; Zang Y; Wang Y; Xue F
Front Oncol; 2022; 12():1001693. PubMed ID: 36531027
[TBL] [Abstract][Full Text] [Related]
86. Estrogen and insulin synergistically promote type 1 endometrial cancer progression.
Tian W; Teng F; Zhao J; Gao J; Gao C; Sun D; Liu G; Zhang Y; Yu S; Zhang W; Wang Y; Xue F
Cancer Biol Ther; 2017 Dec; 18(12):1000-1010. PubMed ID: 29172956
[TBL] [Abstract][Full Text] [Related]
87. PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.
Lu YU; Miyamoto T; Takeuchi H; Tsunoda F; Tanaka N; Shiozawa T
Oncol Res; 2023; 31(3):239-253. PubMed ID: 37305395
[TBL] [Abstract][Full Text] [Related]
88. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer.
Huang P; Fan X; Yu H; Zhang K; Li H; Wang Y; Xue F
J Transl Med; 2023 Feb; 21(1):94. PubMed ID: 36750868
[TBL] [Abstract][Full Text] [Related]
89. Endometrial Expression of Insulin Signaling Pathway Genes in Pregnancy Leading to Abortion under 20 Weeks in Infertile Women: A Case-Control Study.
Namvarsigaroudi N; Tahmasebi Fard Z
Int J Fertil Steril; 2022 Oct; 16(4):286-291. PubMed ID: 36273315
[TBL] [Abstract][Full Text] [Related]
90. Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer.
Cui Z; Mo J; Wang L; Wang R; Cheng F; Wang L; Yang X; Wang W
Front Genet; 2022; 13():906291. PubMed ID: 35923695
[TBL] [Abstract][Full Text] [Related]
91. The Complexity of Response to the Proliferation Agonist and Antagonist Agents, in the Breast Cancer Cell Lines with Various Receptors.
Aryanpour N; Farnam G; Behtaj R; H Shirazi F
Iran J Pharm Res; 2022 Dec; 21(1):e123823. PubMed ID: 35765511
[TBL] [Abstract][Full Text] [Related]
92. Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview.
Gullo G; Etrusco A; Cucinella G; Perino A; Chiantera V; Laganà AS; Tomaiuolo R; Vitagliano A; Giampaolino P; Noventa M; Andrisani A; Buzzaccarini G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769256
[TBL] [Abstract][Full Text] [Related]
93. Insulin Resistance and Cancer: In Search for a Causal Link.
Chiefari E; Mirabelli M; La Vignera S; Tanyolaç S; Foti DP; Aversa A; Brunetti A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681797
[TBL] [Abstract][Full Text] [Related]
94. Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
Fan Y; Li X; Tian L; Wang J
Front Oncol; 2021; 11():630905. PubMed ID: 33763366
[TBL] [Abstract][Full Text] [Related]
95. The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis.
Kulkarni A; Bowers LW
Cell Mol Life Sci; 2021 Apr; 78(7):3423-3442. PubMed ID: 33464384
[TBL] [Abstract][Full Text] [Related]
96. Therapeutic effect of metformin in the treatment of endometrial cancer.
Mu N; Xu T; Gao M; Dong M; Tang Q; Hao L; Wang G; Li Z; Wang W; Yang Y; Hou J
Oncol Lett; 2020 Nov; 20(5):156. PubMed ID: 32934724
[TBL] [Abstract][Full Text] [Related]
97. High serum Androgen and Insulin concentrations increase the tendency of Endometrial Carcinoma.
Teng F; Ma X; Yu X; Yan Y; Zhao J; Gao J; Gao C; Wang Y; Tian W; Xue F
J Cancer; 2020; 11(19):5656-5664. PubMed ID: 32913460
[No Abstract] [Full Text] [Related]
98. Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.
Kyo S; Nakayama K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842547
[TBL] [Abstract][Full Text] [Related]
99. Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways.
Tian W; Teng F; Gao J; Gao C; Liu G; Zhang Y; Yu S; Zhang W; Wang Y; Xue F
Cancer Biol Med; 2019 Feb; 16(1):55-70. PubMed ID: 31119046
[TBL] [Abstract][Full Text] [Related]
100. Microarray pathway analysis indicated that mitogen-activated protein kinase/extracellular signal-regulated kinase and insulin growth factor 1 signaling pathways were inhibited by small interfering RNA against AT-rich interactive domain 1A in endometrial cancer.
Yang Y; Bao W; Sang Z; Yang Y; Lu M; Xi X
Oncol Lett; 2018 Feb; 15(2):1829-1838. PubMed ID: 29399196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
